Centre Francois Baclesse clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   AFTERGYN2 · Impact of a Multidisciplinary Assessment in Day…AFTERGYN2 · Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer

   Primary completion pushed from Sep 7, 2027 to Sep 7, 2028

   Also in this update: Study completion pushed from Jun 7, 2028 to Jun 7, 2029

   Centre Francois Baclesse·Not applicable· NCT06553612· Registry history of NCT06553612 on ClinicalTrials.gov (opens the registry)

   Sep 24, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.